Independent
Tenure on this board
2.7 yrs
10 nominees · 4 ballot items.
Election of ten directors; advisory (non-binding) approval of executive compensation (say-on-pay); ratification of Grant Thornton LLP as independent registered public accounting firm; approval of an amendment to the 2024 Equity Incentive Plan increasing the share reserve by 1,000,000; and consideration of other business as may properly arise.
Elect ten directors to serve until the next annual meeting and until their successors are elected and qualified; all ten nominees are current directors (with one retiring at the meeting) and will be voted on individually.
Advisory (non-binding) vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement.
This non-binding say-on-pay proposal asks shareholders to approve the Company’s executive compensation disclosures and overall pay practices for named executive officers as presented in the proxy statement. Management is seeking an advisory endorsement to confirm that its compensation philosophy—designed to attract and retain executives, tie pay to performance, and align long-term executive incentives with stockholder interests—is supported by the shareholder base; the company notes a 96.24% approval at the 2025 meeting. The compensation program described in the CD&A includes multi-element compensation: base salary, a short-term incentive plan with specific metrics (sales revenue, adjusted operating income, total cash collected, technology adoption, and an individual contribution component), and long-term equity awards (restricted shares, stock options and performance-based awards). The vote is non-binding, but management and the compensation committee state they will consider voting outcomes when setting future compensation practices and may adjust programs if significant dissent occurs. For investors evaluating governance risk, the proposal reflects both the committee’s use of market benchmarking and consultants (Compensia) and the existence of structured performance metrics; it also includes change-in-control and clawback provisions and stock ownership guidelines. The board recommends FOR the proposal, arguing that the program appropriately balances retention, performance incentives, and alignment with stockholders while offering flexibility to respond to market conditions and strategic needs. Key contextual items for analysts include the company’s recent retention program and contingent option grants linked to a plan amendment (Proposal 4), historical high say-on-pay support, and the detailed STI metric design which produced partial payouts in fiscal 2026. A sophisticated evaluation should weigh the advisory nature of the vote, the specific performance metrics and payout outcomes disclosed for 2026, recent leadership changes and retention awards, and potential dilution from equity programs when assessing whether the compensation program serves long-term shareholder value.
Ratify the audit and compliance committee’s selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending April 30, 2027.
Approve an amendment to increase the 2024 Plan share reserve by 1,000,000 shares (from 500,000 to 1,500,000) to permit future equity awards, including contingent retention options.
This proposal requests stockholder approval to amend the 2024 Equity Incentive Plan to increase the aggregate share reserve by 1,000,000 shares (from 500,000 to 1,500,000) and to raise the incentive stock option limit correspondingly. Management argues the increase is required to preserve the Company’s ability to grant equity-based awards to employees, officers, directors and consultants—part of its standard compensation framework to attract, retain and motivate talent—citing that as of August 3, 2026 only 55,654 shares remained available under the plan. The amendment is also explicitly tied to contingent retention option grants made June 3, 2026 (aggregate contingent options of 288,404 shares) that are conditioned on stockholder approval; if the amendment fails, those contingent options will be void ab initio. The board frames approval as necessary to continue historical grant practices and to enable long-term incentive alignment with stockholders, and the audit/compensation committees have recommended the change; the board recommends a vote FOR. From a governance and dilution perspective, analysts should note the magnitude of the requested increase relative to outstanding shares (1,000,000 shares vs. ~8.66 million outstanding as of record date), the specific contingent awards and retention program driving the request, and the plan’s anti-repricing protections, change-in-control vesting provisions and other limits (including a $750,000 annual cap for outside director compensation and mandatory shareholder approval for repricings). The proposal therefore presents a tradeoff between management’s need for equity currency to execute compensation and retention strategies (especially during the strategic review and capital restructuring period) and potential dilution to existing shareholders; investors should evaluate expected grant run-rate, potential future dilution, and the disclosed contingent grants when assessing the proposal’s merits.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | MAGNOLIA GROUP, LLC | 15.14% | 1,260,690 | $16M |
| 2 | Nantahala Capital Management, LLC | 7.74% | 644,686 | $8M |
| 3 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 7.21% | 600,201 | $8M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.96% | 329,491 | $4M |
| 5 | BlackRock, Inc. | 3.26% | 271,335 | $3M |
| 6 | AMERIPRISE FINANCIAL INC | 3.23% | 269,385 | $3M |
| 7 | North Reef Capital Management LP | 3.11% | 258,637 | $3M |
| 8 | BlackRock, Inc. | 2.84% | 236,780 | $3M |
| 9 | KIZE CAPITAL LP | 2.62% | 218,282 | $3M |
| 10 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.50% | 208,109 | $3M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.